{"id":"stamaril-sanofi-pasteur","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Headache"},{"rate":"10-20","effect":"Myalgia"},{"rate":"5-15","effect":"Fever"},{"rate":"5-10","effect":"Injection site reaction"},{"rate":"5-10","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL3923877","moleculeType":"Small molecule","molecularWeight":"406.48"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains a weakened strain of yellow fever virus (17D strain) that replicates in vaccinated individuals without causing disease, triggering both humoral (antibody) and cell-mediated immune responses. This provides long-term protection against infection with wild-type yellow fever virus. The vaccine is administered as a single dose and confers immunity in approximately 95% of vaccinees within 30 days.","oneSentence":"Stamaril is a live attenuated yellow fever vaccine that stimulates the immune system to produce antibodies and cellular immunity against yellow fever virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:01.582Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of yellow fever in endemic regions and travelers to yellow fever-endemic areas"}]},"trialDetails":[{"nctId":"NCT06399003","phase":"PHASE3","title":"Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months","status":"COMPLETED","sponsor":"Shanghai Institute Of Biological Products","startDate":"2024-06-28","conditions":"Measles-Mumps-Rubella","enrollment":1200},{"nctId":"NCT05568953","phase":"PHASE2","title":"An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity","status":"UNKNOWN","sponsor":"Singapore General Hospital","startDate":"2022-09-28","conditions":"Infectious Disease, Yellow Fever, Japanese Encephalitis","enrollment":70},{"nctId":"NCT02991495","phase":"PHASE4","title":"Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)","status":"COMPLETED","sponsor":"Epicentre","startDate":"2017-11-06","conditions":"Yellow Fever","enrollment":1630}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Stamaril, Sanofi Pasteur","genericName":"Stamaril, Sanofi Pasteur","companyName":"Epicentre","companyId":"epicentre","modality":"Biologic","firstApprovalDate":"","aiSummary":"Stamaril is a Yellow Fever vaccine developed by Sanofi Pasteur. It is a small molecule vaccine, classified as a small molecule modality.","enrichmentLevel":3,"visitCount":3,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}